MedTrace Logo

Prediction of Long-term Arm Morbidity Following Breast Cancer Surgeries and Treatments

NCT05950685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1602

Last updated 2025-11-17

No results posted yet for this study

Summary

Background: Breast cancer (BC) treatments usually include a combination of surgery, chemotherapy and radiation. These life-saving treatments cause high percentages of arm morbidity, which often lasts for months, or develops months after surgery. Arm and shoulder morbidity includes prolonged pain, restriction of movement, limitation of function and lymphedema (chronic progressive edema). All of these morbidities affect the quality of life (QOL) of the recovering patients and require lengthy care. Early detection of patients at risk and provision of proactive treatment can improve the recovery process from surgery and oncology treatments.

Aim: To develop a screening tool for the early identification of women at high risk for prolonged arm morbidity following BC treatments (persistent pain, lymphedema, function deficits and decreased range of motion), validate the tool, and examine the efficiency of intervention based on the the use of the tool.

Conditions

Sponsors & Collaborators

  • Ben-Gurion University of the Negev

    collaborator OTHER

  • Ifat Klein

    lead OTHER

Principal Investigators

  • Merav Ben- David, Professor · Assuta Medical Center

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2025-05-01
Completion
2025-06-01

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05950685 on ClinicalTrials.gov